We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
11 hedge funds and large institutions have $521K invested in Windtree Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
10% more funds holding
Funds holding: 10 → 11 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
22% less capital invested
Capital invested by funds: $666K → $521K (-$146K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$35.7K |
| 2 |
VF
Virtu Financial
New York
|
+$35.7K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$17.9K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$17.9K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$53.6K |
| 2 |
Millennium Management
New York
|
-$35.7K |
| 3 |
Two Sigma Advisers
New York
|
-$35K |
| 4 |
Renaissance Technologies
New York
|
-$17.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.9K |
